Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
Cancer Cell · 2025-03 · 43 (3) · 446-463.e7
DOI: 10.1016/j.ccell.2025.01.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-03. Verfasst von Yuanyuan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of M…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immune Checkpoint Inhibitors, B7-H1 Antigen, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, Chin…
- Department of Medical Oncology, Cancer Hospital of HuanXing, ChaoYang District, Beijing 100005, China.
- BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.
- BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China. Electronic address: zemin@pku.edu.cn.
Zitieren
APA
Zhang, Y., Chen, H., Mo, H., Zhao, N., Sun, X., Liu, B., Gao, R., Xu, B., Zhang, Z., Liu, Z., & Ma, F. (2025). Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer. Cancer Cell, 43(3), 446-463.e7. https://doi.org/10.1016/j.ccell.2025.01.007
Vancouver
Zhang Y, Chen H, Mo H, Zhao N, Sun X, Liu B, et al. Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer. Cancer Cell. 2025;43(3):446-463.e7. doi:10.1016/j.ccell.2025.01.007
BibTeX
@article{Zhang2025,
author = {Zhang, Yuanyuan and Chen, Hongyan and Mo, Hongnan and Zhao, Ning and Sun, Xiaoying and Liu, Baolin and Gao, Ranran and Xu, Binghe and Zhang, Zemin and Liu, Zhihua and Ma, Fei},
title = {Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {3},
pages = {446--463.e7},
doi = {10.1016/j.ccell.2025.01.007}
}
EUVIMED